col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Ovid: Hypertension
  original article Date Title Authors   All Authors
1 [GO] 2021―Aug―27 Abstract P265: Hypertension, Vascular Dysfunction And Downregulation Of The Renin Angiotensin System Sequelae Of COVID-19 Linsay McCallum, Stefanie Lip, Francisco J Rios, Karla B Neves, Jason Kilmartin, Eleanor Murray, et al. (+11)
2 [GO] 2021―Aug―27 Abstract P259: Cardiovascular Pharmacotherapy And Covid-19 Stefanie Lip, Linsay McCallum, Clea du Toit, Jason Kilmartin, Eleanor Murray, Salil Reetoo, et al. (+7)
3 [GO] 2021―Aug―27 Abstract P269: Influence Of Sex, Race, And Changes In Vital Signs In Covid-19 And Flu Diagnosed Patients In Mississippi Brigitte E Martin, Michael R Garrett
4 [GO] 2021―Aug―27 Abstract P268: The Impact Of Covid-19 On A Large Pragmatic Clinical Trial Embedded In Primary Care Cynthia Hau, Sarah Leatherman, Alison Klint, Peter Glassman, Addison Taylor, WILLIAM CUSHMAN, Areef Ishani
5 [GO] 2021―Aug―27 Abstract P258: The Use Of Ace Inhibitors And Angiotensin Receptor Blockers Is Associated With Decreased Mortality And Increased Hospitalization Rate In Covid-19 Patients Aaron Douen, Jeremy Oh, Wesley Romney, Ryan Panetti, Prakash Ramdass, Aleksandre Toreli, George Juang
6 [GO] 2021―Aug―27 Abstract P267: Arbidol, A Targeted Covid-19 Therapy, Inhibited Contractile Responses To Phenylephrine In Mesenteric Arteries And Aortas Of Hypertensive Rats Olufunke O Arishe, Stephanie Wilczynski, Anna Thamasett, Clinton R Webb
7 [GO] 2021―Aug―27 Abstract P266: Hypertensive Response In Recently Covid-19 Vaccinated Patients ELIAS SANIDAS, DIMITRIOS PAPADOPOULOS, MARINA MANTZOURANI, MARIA VELLIOU, THEOCHARIS ANASTASIOU, ANASTASIA FOTSALI, JOHN BARBETSEAS
8 [GO] 2021―Aug―27 Abstract P261: Is Hypertension A Clinically Important Independent Risk Factor For Critical Illness In Covid-19? Anthi Katsouli, Sadia Gazi, Paula Marfia, Helen Lee, Sameer Qazi, Monica Komorowski, et al. (+2)
9 [GO] 2021―Aug―27 Abstract P262: Spike Protein 1 Of Sars-cov-2 Increases Interferon Stimulated Genes And Induces An Immune/inflammatory Responses In Human Endothelial Cells. Francisco J Rios, Augusto C Montezano, Livia L Camargo, Rheure A Lopes, Eihu Aranday-Cortes, John McLauchlan, Rhian M Touyz
10 [GO] 2021―Aug―27 Abstract MP30: Circulating Sars-cov-2 Spike Protein 1 Causes Microarteriolar Oxidative Stress, Endothelial Dysfunction And Enhanced Thromboxane And Endothelin Contractility That Are Prevented By Spironolactone. Dan Wang, Christopher S Wilcox
11 [GO] 2021―Aug―27 Abstract MP62: Sars-cov-2 Spike Protein Regulation Of Angiotensin Converting Enzyme 2 And Tissue Renin-angiotensin Systems: Influence Of Biologic Sex Lisa A Cassis, Christopher M Waters, Robin C Shoemaker, Jamie Sturgill, Yasir AlSiraj, Mark Ensor
12 [GO] 2021―Aug―27 Abstract P260: SARS-Cov-2 Spike Protein S1-Mediated Endothelial Injury And Pro-Inflammatory State Is Amplified By Dihydrotestosterone And Prevented By Mineralocorticoid Antagonism Nitin Kumar, Kristina Hunker, Yogendra Kanthi, Andrea T Obi, Santhi Ganesh
13 [GO] 2021―Aug―27 Abstract P263: Symptomatic Post-Acute SARS-CoV-2-Infection Hypertension Syndrome Lauren East, Zainab Mahmoud, Amanda Verma
14 [GO] 2021―Aug―27 Abstract 40: SARS-CoV-2/ACE2 Induces Vascular Inflammatory Responses In Human Microvascular Endothelial Cells Independently Of Viral Replication Augusto C Montezano, Livia Camargo, Sheon Mary, Karla B Neves, Francisco J Rios, Rheure Alves-lopes, et al. (+8)
15 [GO] 2021―Aug―27 Abstract P264: Protective Effects Of Angiotensin II Inhibitors In Lebanese SARS-COV2 Hospitalized Patients Farah Abdulhai, Souha Fares, Wissam Mekary, Nada J Habeichi, Gaelle P Massoud, Marwan M Refaat, Fouad A Zouein
16 [GO] 2021―Jun―09 Discontinuation of Antihypertensive Medications on the Outcome of Hospitalized Patients With Severe Acute Respiratory Syndrome-Coronavirus 2 Sandeep Singh, Annette K. Offringa-Hup, Susan J.J. Logtenberg, Paul D. Van der Linden, Wilbert M.T. Janssen, Hubertina Klein, et al. (+9)
17 [GO] 2021―May―10 First-Phase Ejection Fraction, a Measure of Preclinical Heart Failure, Is Strongly Associated With Increased Mortality in Patients With COVID-19 Haotian Gu, Chiara Cirillo, Adam A. Nabeebaccus, Zhenxing Sun, Lingyun Fang, Yuji Xie, et al. (+30)
18 [GO] 2021―Mar―25 Stage III hypertension in patients after mRNA-based SARS-CoV-2 vaccination Sylvain Meylan, Francoise Livio, Maryline Foerster, Patrick James Genoud, Francois Marguet, Grégoire Wuerzner
19 [GO] 2021―Feb―10 Could Renin-Angiotensin System Inhibitors Be Protective From Severe COVID-19? Robert M. Carey
20 [GO] 2021―Jan―20 Angiotensin Type 1 Receptor-Dependent Internalization of SARS-CoV-2 by Angiotensin Converting Enzyme 2 Blessing O Ogunlade, Eric Lazartigues, Catalin M. Filipeanu
21 [GO] 2021―Jan―11 Antihypertensive Drugs and COVID-19 Risk Laura Semenzato, Jérémie Botton, Jérôme Drouin, Bérangère Baricault, Clémentine Vabre, François Cuenot, et al. (+6)
22 [GO] 2020―Dec―30 Impact of arterial stiffness on all-cause mortality in patients hospitalized with COVID-19 in Spain Enrique Rodilla, Maria Dolores Lopez-Carmona, Xavi Cortes, Lidia Cobos-Palacios, Sergio Canales, Maria Carmen Saez, et al. (+19)
23 [GO] 2020―Dec―16 The association between blood pressure control and Coronavirus Disease 2019 outcomes in 45,418 symptomatic patients with hypertension: An observational cohort study James P. Sheppard, Brian Nicholson, Joseph Lee, Dylan McGagh, Julian Sherlock, Constantinos Koshiaris, et al. (+15)
24 [GO] 2020―Dec―02 Butyrate Regulates COVID-19-Relevant Genes in Gut Epithelial Organoids from Normotensive Rats Jing Li, Elaine M. Richards, Eileen Handberg, Carl J. Pepine, Mohan K. Raizada
25 [GO] 2020―Oct―07 Correction to: Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study
26 [GO] 2020―Sep―28 Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System Matthew A. Sparks, Andrew M. South, Andrew D. Badley, Carissa M. Baker-Smith, Daniel Batlle, Biykem Bozkurt, et al. (+13)
27 [GO] 2020―Sep―24 Proteomic analysis reveals upregulation of ACE2, the putative SARS-CoV-2 receptor in pressure- but not volume-overloaded human hearts Johannes Stegbauer, Milena Kraus, Sarah Nordmeyer, Marieluise Kirchner, Matthias Ziehm, Henrik Dommisch, et al. (+11)
28 [GO] 2020―Sep―09 Abstract P135: Covid-19 And Hypertension: Pooled Analysis Of Observational Studies Vikramaditya Reddy Samala Venkata, Rahul Gupta, Surya Kiran Aedma
29 [GO] 2020―Sep―09 Abstract P144: Covid-19 And The Use Of Angiotensin-converting Enzyme Inhibitors And Receptor Blockers. Real World Experience. Baher AL Abbasi, Nakeya Dewaswala, Fergie Ramos, Ahmed Abdallah, Pedro Torres, Kai Chen, et al. (+5)
30 [GO] 2020―Sep―09 Abstract P232: Dilated Cardiomyopathy With Electrocardiographic Changes And Coronary-Pulmonary Fistula: An Uncommon Presentation Of Primary Aldosteronism In The Covid-19 Era Luigi Marzano, Giovanni Scanelli
31 [GO] 2020―Sep―09 Abstract P145: Blood Pressure De-regulation And Renal Function Are Main Determinants Of Covid-19 Mortality Chiara Livia Lanzani, Marco Simonini, Elisabetta Messaggio, Teresa Arcidiacono, Romina Bucci, Paolo Betti, et al. (+4)
32 [GO] 2020―Sep―01 Renin-angiotensin-aldosterone System Inhibitors and Risks of SARS-CoV-2 Infection: A Systematic Review and Meta-analysis Chieh-Kai Chan, Yu-Shan Huang, Hung-Wei Liao, I-Jung Tsai, Chiao-Yin Sun, Heng-Chih Pan, et al. (+4)
33 [GO] 2020―Aug―27 Plasma Angiotensin Peptide Profiling and ACE2-Activity in COVID-19 Patients treated with Pharmacological Blockers of the Renin Angiotensin System Ulrich Kintscher, Anna Slagman, Oliver Domenig, Robert Röhle, Frank Konietschke, Marko Poglitsch, Martin Möckel
34 [GO] 2020―Aug―27 The interaction of SARS-CoV-2 and other coronavirus with Angiotensin Converting Enzyme 2 (ACE2) as their main receptor: therapeutic implications Anne M Davidson, Jan Wysocki, Daniel Batlle
35 [GO] 2020―Aug―12 What Kind of Evidence Is Needed to Dictate Practice Regarding Inhibitors of the Renin-Angiotensin System in COVID-19? Fernando Elijovich, Cheryl L. Laffer
36 [GO] 2020―Jul―15 Effects of Renin-Angiotensin Inhibition on ACE2 and TMPRSS2 Expression: Insights into COVID-19 Congqing Wu, Dien Ye, Adam E Mullick, Zhenyu Li, A.H. Jan Danser, Alan Daugherty, Hong S. Lu
37 [GO] 2020―Jul―15 Redefining cardiac biomarkers in predicting mortality of inpatients with COVID-19 Juan-Juan Qin, Xu Cheng, Feng Zhou, Fang Lei, Gauri Akolkar, Jingjing Cai, et al. (+36)
38 [GO] 2020―Jul―13 Clinical Features of COVID-19 in Patients With Essential Hypertension and the Impacts of Renin-angiotensin-aldosterone System Inhibitors on the Prognosis of COVID-19 Patients Wei Pan, Jishou Zhang, Menglong Wang, Jing Ye, Yao Xu, Bo Shen, et al. (+12)
39 [GO] 2020―Jul―13 Association Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection in South Korea Minkook Son, Jeongkuk Seo, Sung Yang
40 [GO] 2020―Jul―09 SARS-CoV-2 Receptor ACE2 is upregulated in Colonic Organoids from Hypertensive Rats Jing Li, Bruce R. Stevens, Elaine M. Richards, Mohan K. Raizada
41 [GO] 2020―Jun―22 Age and Multimorbidity Predict Death Among COVID-19 Patients Guido Iaccarino, Guido Grassi, Claudio Borghi, Claudio Ferri, Massimo Salvetti, Massimo Volpe, et al. (+68)
42 [GO] 2020―Jun―04 Comparative impacts of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on the risk of COVID-19 mortality Feng Zhou, Ye-Mao Liu, Jing Xie, Haomiao Li, Fang Lei, Huilin Yang, et al. (+26)
43 [GO] 2020―Jun―01 COVID-19: ACE2centric infective disease? Paolo Verdecchia, Claudio Cavallini, Antonio Spanevello, Fabio Angeli
44 [GO] 2020―May―27 Decreased Mortality of COVID-19 with Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients with Hypertension: A Meta-Analysis Xiaoming Guo, Yueli Zhu, Yuan Hong
45 [GO] 2020―May―21 Evidence that Renin-Angiotensin System Inhibitors Should not be Discontinued Due to the COVID-19 Pandemic Robert M. Carey, Ji-Guang Wang
46 [GO] 2020―May―19 Gnotobiotic Rats Reveal that Gut Microbiota Regulates Colonic mRNA of Ace2 , the Receptor for SARS-CoV-2 Infectivity Tao Yang, Saroj Chakraborty, Piu Saha, Blair Mell, Xi Cheng, Ji-Youn Yeo, et al. (+14)
47 [GO] 2020―May―08 Controversial Relationship between Renin-Angiotensin System Inhibitors and Severity of COVID-19: Announcing a Large Multicentre Case-Control Study in Italy Augusto Di Castelnuovo, Raffaele De Caterina, Giovanni de Gaetano, Licia Iacoviello
48 [GO] 2020―May―08 RAAs inhibitors and outcome in patients with SARS-CoV-2 pneumonia. A case series study. Andrea Conversano, Francesco Melillo, Antonio Napolano, Evgeny Fominskiy, Marzia Spessot, Fabio Ciceri, Eustachio Agricola
49 [GO] 2020―May―05 ACE2, COVID-19, and ACE Inhibitor and ARB Use during the Pandemic: The Pediatric Perspective Andrew M. South, Tammy M. Brady, Joseph T. Flynn
50 [GO] 2020―Apr―29 Effects Of ARBs And ACEIs On Virus Infection, Inflammatory Status And Clinical Outcomes In COVID-19 Patients With Hypertension: A Single Center Retrospective Study Guang Yang, Zihu Tan, Ling Zhou, Min Yang, Lang Peng, Jinjin Liu, et al. (+5)
51 [GO] 2020―Mar―25 Renin-Angiotensin System Blockers and the COVID-19 Pandemic A.H. Jan Danser, Murray Epstein, Daniel Batlle


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.005 sec